Assertio Holdings (ASRT) Research & Development (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Research & Development came in at $454000.0 in Q1 2026, up 3.65% year-on-year from $438000.0 in Q1 2025, and down 6.58% quarter-over-quarter from $486000.0 in Q4 2025.
Assertio Holdings (ASRT) Research & Development (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Research & Development across 6 years of filings, most recently posting $454000.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $454000.0, up 3.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 51.63% YoY), and the FY2025 annual result was $1.7 million, down 55.78% from the prior year.
- Research & Development came in at $454000.0 for Q1 2026 at Assertio Holdings, down from $486000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.3 million in Q3 2023 to a low of $379000.0 in Q3 2025.
- The 4-year median for Research & Development is $618000.0 (2023), against an average of $734083.3.
- Across the five-year window, Research & Development surged 58.65% in 2024 and slumped 62.29% in 2025, its largest moves.
- Assertio Holdings' Research & Development stood at $1.0 million in 2023, then climbed by 25.59% to $1.3 million in 2024, then sank by 62.21% to $486000.0 in 2025, then retreated by 6.58% to $454000.0 in 2026.
- The last three Research & Development figures came in at $454000.0 (Q1 2026), $486000.0 (Q4 2025), and $379000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | 454,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,000.00 |
| Dec 31, 2025 | 486,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 387,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 798,000.00 |
| Mar 31, 2024 | 733,000.00 |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 503,000.00 |
| Dec 31, 2020 | 230,000.00 |
| Sep 30, 2020 | 1.32 Mn |
| Jun 30, 2020 | 1.63 Mn |
| Mar 31, 2020 | 1.04 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Sep 30, 2019 | 1.48 Mn |
| Jun 30, 2019 | 1.26 Mn |